IBSA PHARMA INC Recalls

All product recalls associated with IBSA PHARMA INC.

Get alerts for this brand

Recall Summary

Total Recalls

15

Past Year

0

Class I (Serious)

0

Most Recent

Jan 2023

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 1–15 of 15 recalls

TIROSINT-SOL Levothyroxine Solution 175mcg (IBSA) – Subpotent (2023)

Subpotent Drug

Class IIModerate

FDAJan 30, 2023Nationwide• IBSA PHARMA INC

TIROSINT-SOL Levothyroxine Solution 137mcg (IBSA) – Subpotent (2023)

Subpotent Drug

Class IIModerate

FDAJan 30, 2023Nationwide• IBSA PHARMA INC

TIROSINT-SOL Levothyroxine Solution 37.5mcg (IBSA) – Subpotent (2023)

Subpotent Drug

Class IIModerate

FDA

Jan 30, 2023

Nationwide

• IBSA PHARMA INC

TIROSINT-SOL Levothyroxine Solution 112mcg (IBSA) – Subpotent (2023)

Subpotent Drug

Class IIModerate

FDAJan 30, 2023Nationwide• IBSA PHARMA INC

TIROSINT-SOL Levothyroxine Solution 75mcg (IBSA) – Subpotent (2023)

Subpotent Drug

Class IIModerate

FDAJan 30, 2023Nationwide• IBSA PHARMA INC

TIROSINT-SOL Levothyroxine Solution 62.5mcg (IBSA) – Subpotent (2023)

Subpotent Drug

Class IIModerate

FDAJan 30, 2023Nationwide• IBSA PHARMA INC

TIROSINT-SOL Levothyroxine Solution 200mcg (IBSA) – Subpotent (2023)

Subpotent Drug

Class IIModerate

FDAJan 30, 2023Nationwide• IBSA PHARMA INC

TIROSINT-SOL Levothyroxine Solution 13mcg (IBSA) – Subpotent (2023)

Subpotent Drug

Class IIModerate

FDAJan 30, 2023Nationwide• IBSA PHARMA INC

TIROSINT-SOL Levothyroxine Solution 25mcg (IBSA) – Subpotent (2023)

Subpotent Drug

Class IIModerate

FDAJan 30, 2023Nationwide• IBSA PHARMA INC

TIROSINT-SOL Levothyroxine Solution 100mcg (IBSA) – Subpotent (2023)

Subpotent Drug

Class IIModerate

FDAJan 30, 2023Nationwide• IBSA PHARMA INC

TIROSINT-SOL Levothyroxine Solution 125mcg (IBSA) – Subpotent (2023)

Subpotent Drug

Class IIModerate

FDAJan 30, 2023Nationwide• IBSA PHARMA INC

TIROSINT-SOL Levothyroxine Solution 150mcg (IBSA) – Subpotent (2023)

Subpotent Drug

Class IIModerate

FDAJan 30, 2023Nationwide• IBSA PHARMA INC

Tirosint-SOL (IBSA) - Subpotent Drug (2023)

Subpotent Drug

Class IIModerate

FDAJan 30, 2023Nationwide• IBSA PHARMA INC

TIROSINT-SOL Levothyroxine Solution 88mcg (IBSA) – Subpotent (2023)

Subpotent Drug

Class IIModerate

FDAJan 30, 2023Nationwide• IBSA PHARMA INC

TIROSINT-SOL Levothyroxine Solution 50mcg (IBSA) – Subpotent (2023)

Subpotent Drug

Class IIModerate

FDAJan 30, 2023Nationwide• IBSA PHARMA INC

Stay Informed

IBSA PHARMA INC Recalls

Recall Summary

TIROSINT-SOL Levothyroxine Solution 175mcg (IBSA) – Subpotent (2023)

TIROSINT-SOL Levothyroxine Solution 137mcg (IBSA) – Subpotent (2023)

TIROSINT-SOL Levothyroxine Solution 37.5mcg (IBSA) – Subpotent (2023)

TIROSINT-SOL Levothyroxine Solution 112mcg (IBSA) – Subpotent (2023)

TIROSINT-SOL Levothyroxine Solution 75mcg (IBSA) – Subpotent (2023)

TIROSINT-SOL Levothyroxine Solution 62.5mcg (IBSA) – Subpotent (2023)

TIROSINT-SOL Levothyroxine Solution 200mcg (IBSA) – Subpotent (2023)

TIROSINT-SOL Levothyroxine Solution 13mcg (IBSA) – Subpotent (2023)

TIROSINT-SOL Levothyroxine Solution 25mcg (IBSA) – Subpotent (2023)

TIROSINT-SOL Levothyroxine Solution 100mcg (IBSA) – Subpotent (2023)

TIROSINT-SOL Levothyroxine Solution 125mcg (IBSA) – Subpotent (2023)

TIROSINT-SOL Levothyroxine Solution 150mcg (IBSA) – Subpotent (2023)

Tirosint-SOL (IBSA) - Subpotent Drug (2023)

TIROSINT-SOL Levothyroxine Solution 88mcg (IBSA) – Subpotent (2023)

TIROSINT-SOL Levothyroxine Solution 50mcg (IBSA) – Subpotent (2023)